| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ec872637dd23aee3ea8f3de7258301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e711d23be007c72d9a98b809a1db7fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_789d4daaed8fd24cfffc812c07ede6f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_391c83fca792eb7f88e731abaf38d305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5eb6c525e93546be6a42a6cee636cf84 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcd4ac5b1b8b74c3f80f9eb1599523d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ca49dcf32c968b2d9015236bae0f83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8595a24d1c3517a2f532421c50af19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75668e808d97542b89a196496a667b27 |
| publicationDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011153327-A1 |
| titleOfInvention |
Methods of treating hepatic encephalopathy |
| abstract |
Treatment of hepatic encephalopathy using gastrointestinal specific antibiotics is disclosed. One example of a gastrointestinal specific antibiotic is rifaximin. The instant application also provides methods for determining if a subject has a neurological condition or hepatic encephalopathy by determining the critical flicker frequency and/or the venous ammonia level of the subject at two or more time points. The further provided are methods for treating these subjects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2442803-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2442803-A1 |
| priorityDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |